Keyphrases
Pathophysiology
100%
Mammalian Target of Rapamycin (mTOR)
100%
Diabetic Nephropathy
100%
Proximal Tubule
100%
Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i)
100%
Renal Tubular Epithelial Cells
83%
Diabetes
66%
Diabetic Kidney Disease
33%
Protective Effect
16%
Gene Expression
16%
Constitutive Activation
16%
Fibrosis
16%
Fibrogenesis
16%
Kidney Disease
16%
Partial Inhibition
16%
Renal Failure
16%
Renal Fibrosis
16%
Profibrotic
16%
Renal Cortex
16%
End-stage Renal Disease
16%
Interstitial Fibrosis
16%
Advanced Kidney Disease
16%
Renal Protection
16%
Decline in Kidney Function
16%
Medicine and Dentistry
Pathophysiology
100%
Diabetic Nephropathy
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Diabetes
80%
Gene Expression
20%
Kidney Function
20%
Fibrosis
20%
Fibrogenesis
20%
Nephropathy
20%
Renal Failure
20%
End Stage Renal Disease
20%
Idiopathic Pulmonary Fibrosis
20%
Kidney Fibrosis
20%
Kidney Dysfunction
20%
Pharmacology, Toxicology and Pharmaceutical Science
Pathophysiology
100%
Diabetic Nephropathy
100%
Sodium Glucose Cotransporter 2 Inhibitor
100%
Fibrosis
20%
Kidney Disease
20%
Kidney Failure
20%
End Stage Renal Disease
20%
Kidney Dysfunction
20%
Fibrosing Alveolitis
20%
Kidney Fibrosis
20%